Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

Exelixis (EXEL) announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

small intestine cancers are rare in the United States. In fact, they account for fewer than 1 in 10 cancers of the gastrointestinal (GI) tract, and fewer than 1 in 100 cancers overall. The American ...

Get Instant Summarized Text (Gist) CD74 protein levels can predict immunotherapy response in bowel cancer, regardless of subtype. This discovery could expand treatment eligibility to patients with ...

Researchers at the Francis Crick Institute and Barts Cancer Institute, Queen Mary University of London, have shown that the amount of a protein called CD74 can indicate which people with bowel ...

All 50-74-year-olds in England will now receive a home-testing kit for bowel cancer every ... his local hospital detected a small lesion, found to be early-stage cancer. Keyhole surgery removed ...

Functional pancreatic tumors, although less common than small bowel neuroendocrine tumors (NETs), can have a profound impact on patients’ quality of life. There is a paucity of data on functional ...

14% of medium businesses were owned by women 20% of small businesses were owned by women 14% of micro businesses (0-9 employees) were owned by women 24% of SMEs in the UK are defined as “equally ...

gestational trophoblastic neoplasia (GTN), fallopian tube cancer, adrenocortical carcinoma, neuroendocrine carcinoma, pancreatic adenocarcinoma, duodenum and small bowel adenocarcinoma, gastric and ...

Adenocarcinomas from multiple tissues can converge to treatment-resistant small cell neuroendocrine (SCN) cancers composed of ASCL1, POU2F3, NEUROD1, and YAP1 subtypes. We investigated how ...